A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
Obninsk Institute for Nuclear Power Engineering, National Research Nuclear University MEPhI, Obninsk, Russia.
Bull Exp Biol Med. 2024 Mar;176(5):626-630. doi: 10.1007/s10517-024-06081-4. Epub 2024 May 11.
We studied the antitumor activity of the combined use of local proton irradiation in two modes (10 and 31 Gy) with preliminary intra-tumoral injection of two types of bismuth nanoparticles differing in surface coating: coated with the amphiphilic molecule Pluronic-F127 or Silane-PEG (5 kDa)-COOH polymer. Nanoparticles were used in doses of 0.75 and 1.5 mg/mouse. In two independent series on experimental tumor model (solid Ehrlich carcinoma), bismuth nanoparticles of both modifications injected directly into the tumor enhanced the antitumor effects of proton therapy. Moreover, the radiosensitizing effect of bismuth nanoparticles administered via this route increased with the increasing the doses of nanoparticles and the doses of radiation exposure. In our opinion, these promising data obtained for the first time extend the possibilities of treating malignant neoplasms.
我们研究了局部质子照射两种模式(10 和 31 Gy)与两种类型的铋纳米粒子联合使用的抗肿瘤活性,这两种类型的铋纳米粒子在表面涂层上有所不同:一种用两亲分子 Pluronic-F127 涂层,另一种用 Silane-PEG(5 kDa)-COOH 聚合物涂层。纳米粒子的使用剂量为 0.75 和 1.5 mg/只小鼠。在两个独立的实验肿瘤模型(固体 Ehrlich 癌)系列中,直接注射到肿瘤中的两种修饰的铋纳米粒子增强了质子治疗的抗肿瘤作用。此外,通过这种途径给予的铋纳米粒子的放射增敏作用随着纳米粒子剂量和辐射暴露剂量的增加而增加。我们认为,这些首次获得的有前景的数据扩展了治疗恶性肿瘤的可能性。